Ampio Pharmaceuticals (AMPE) Sees Unusually-High Trading Volume

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) shares saw an uptick in trading volume on Thursday . 17,061,155 shares changed hands during mid-day trading, an increase of 2,751% from the previous session’s volume of 598,334 shares.The stock last traded at $2.33 and had previously closed at $1.75.

Separately, ValuEngine raised shares of Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 11th.

ILLEGAL ACTIVITY WARNING: “Ampio Pharmaceuticals (AMPE) Sees Unusually-High Trading Volume” was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.com-unik.info/2017/12/16/ampio-pharmaceuticals-ampe-sees-unusually-high-trading-volume.html.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.

What are top analysts saying about Ampio Pharmaceuticals? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Ampio Pharmaceuticals and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit